WALTHAM, Mass., Aug. 20 /PRNewswire-FirstCall/ -- Thermo Fisher Scientific Inc. (NYSE: TMO) announced today that certain executive officers, including Marijn E. Dekkers, president and chief executive officer, are adopting stock- trading programs under Securities and Exchange Commission (SEC) Rule 10b5-1 covering the future sale of company stock. Mr. Dekkers, who exercised options for and sold 300,000 shares over August 15-17, 2007, has adopted a plan for the future sale of up to an additional 780,000 shares, which he would acquire upon the exercise of stock options granted in 2002. Mr. Dekkers entered into this program in order to diversify his financial holdings, although he will continue to have a significant ownership interest in the company. After selling these shares, Mr. Dekkers would own shares, or share equivalents, and hold options totaling 1,860,378 shares.
These trading programs are based on SEC Rule 10b5-1, which protects company executives from possible claims of insider trading by permitting them to buy or sell a predetermined amount of their company's shares, as set forth in a planned acquisition or divestiture program that was adopted when the insider did not possess any material non-public information.
About Thermo Fisher Scientific
Thermo Fisher Scientific (NYSE: TMO) is the world leader in serving
science, enabling our customers to make the world healthier, cleaner and
safer. With an annual revenue rate of more than $9 billion, we employ
|SOURCE Thermo Fisher Scientific Inc.|
Copyright©2007 PR Newswire.